Ciaran Flanagan

Ciaran Flanagan

VP, Global Commercial Translational Pharmaceutics

Business Development
About

Ciaran Flanagan is the VP, Commercial at Quotient Sciences, leading a business development team specialising in Quotient’s unique Translational Pharmaceutics® platform, which helps to accelerate drug product development by integrating formulation development, on-demand GMP manufacturing, and clinical testing.

Ciaran holds a degree in Biological Sciences from the University of Sheffield, and has over 20 years of commercial experience in contract research & development and clinical pharmacology services.

 

Quotient Sciences Logo
Translational Pharmaceutics, Formulation Development, Peptides, Dr. Andrew Lewis

Using a formulation design space with Translational Pharmaceutics® for success in oral peptide development

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More